Roughly one in 15 children receiving cancer treatment in low- and middle-income countries, or LMICs, die from treatment-related complications, new research published in The Lancet Oncology said.
News Today | First with the news
News Today | First with the news
Roughly one in 15 children receiving cancer treatment in low- and middle-income countries, or LMICs, die from treatment-related complications, new research published in The Lancet Oncology said.